Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Jan-22 | Jan-23 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 6,045 | 6,238 | 6,265 | 7,284 | 7,242 | 6,266 | 2,329 | 2,585 | 1,813 | 1,342 | | 1,288 |
% Growth | NA | 3.2% | 0.4% | 16.3% | -0.6% | -13.5% | -62.8% | 11.0% | -29.9% | -25.9% | | |
| | | | | | | | | | | | |
Cost of Revenue | (4,997) | (5,120) | (5,093) | (5,890) | (5,866) | (5,054) | (1,300) | (1,393) | (922) | (522) | | (530) |
Gross Profit | 1,048 | 1,118 | 1,173 | 1,393 | 1,376 | 1,212 | 1,029 | 1,191 | 891 | 821 | | 758 |
% Revenue | 17.3% | 17.9% | 18.7% | 19.1% | 19.0% | 19.3% | 44.2% | 46.1% | 49.1% | 61.1% | | 58.9% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | (10) | (12) | (7) | (2) | 0 | | 0 |
Selling and Marketing | (257) | (300) | (397) | (411) | (499) | (455) | (466) | (471) | (346) | (310) | | (293) |
General and Admin | (283) | (300) | (391) | (435) | (472) | (473) | (482) | (548) | (554) | (530) | | (499) |
Other Inc / (Exp) | (75) | (101) | (59) | (129) | (79) | (114) | (151) | (104) | (64) | (41) | | (27) |
Total Operating Exp | (616) | (702) | (847) | (975) | (1,050) | (1,051) | (1,112) | (1,130) | (966) | (881) | | (819) |
| | | | | | | | | | | | |
Operating Income | 432 | 416 | 326 | 418 | 327 | 161 | (83) | 61 | (76) | (61) | | (61) |
% Revenue | 7.1% | 6.7% | 5.2% | 5.7% | 4.5% | 2.6% | -3.6% | 2.4% | -4.2% | -4.5% | | -4.7% |
| | | | | | | | | | | | |
Interest Expense | 40 | 2 | 29 | 236 | 181 | 149 | 131 | 48 | 93 | 85 | | 112 |
Pre-tax Income | 472 | 418 | 355 | 654 | 508 | 310 | 47 | 109 | 17 | 24 | | 52 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (137) | (118) | (133) | (125) | (120) | (108) | (45) | (35) | (13) | (2) | | (1) |
Net Income to Company | 335 | 301 | 222 | 529 | 388 | 202 | 2 | 74 | 4 | 22 | | 51 |
% Margin | 5.5% | 4.8% | 3.5% | 7.3% | 5.4% | 3.2% | 0.1% | 2.9% | 0.2% | 1.7% | | 3.9% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 17 | 9 | 77 | 36 | 66 | 115 | 137 | 57 | 29 | 26 | | 25 |
Net Income to Stockholders | 352 | 310 | 299 | 565 | 454 | 317 | 139 | 131 | 33 | 49 | | 76 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 352 | 310 | 299 | 565 | 454 | 317 | 139 | 131 | 33 | 49 | | 76 |
% Margin | 5.8% | 5.0% | 4.8% | 7.8% | 6.3% | 5.1% | 6.0% | 5.1% | 1.8% | 3.6% | | 5.9% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.31 | 0.27 | 0.24 | 0.40 | 0.32 | 0.23 | 0.10 | 0.09 | 0.02 | 0.04 | | 0.05 |
Diluted EPS (Continuing Ops) | 0.31 | 0.27 | 0.24 | 0.40 | 0.32 | 0.23 | 0.10 | 0.09 | 0.02 | 0.04 | | 0.05 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 1,124.78 | 1,131.64 | 1,264.46 | 1,405.75 | 1,399.74 | 1,394.87 | 1,390.44 | 1,390.65 | 1,377.44 | 1,389.04 | | 1,390.68 |
WA Diluted Shares Out. | 1,124.78 | 1,131.64 | 1,264.46 | 1,405.75 | 1,399.74 | 1,394.87 | 1,390.44 | 1,390.65 | 1,377.44 | 1,389.04 | | 1,390.68 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 472 | 418 | 355 | 654 | 508 | 310 | 47 | 109 | 17 | 24 | | 52 |
Addback: Net Interest Expense | (40) | (2) | (29) | (236) | (181) | (149) | (131) | (48) | (93) | (85) | | (112) |
Addback: Other Non Operating Expenses, Total | (10) | (12) | (17) | (18) | (12) | (11) | 63 | 18 | 15 | 12 | | 7 |
Addback: Depreciation & Amortization | 101 | 121 | 175 | 200 | 212 | 221 | 224 | 330 | 222 | 215 | | 210 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 42 | 41 | 27 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (0) | 12 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | (19) | 0 | 1 | 0 | 0 | 0 | (0) | (26) | | (26) |
Addback: Asset Writedown | 0 | 0 | 0 | 9 | 0 | 4 | 1 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 10 | 11 | 1 | 8 | (5) | (12) | 0 | (23) | (20) | (10) | | (29) |
Adjusted EBITDA | 533 | 549 | 469 | 617 | 522 | 406 | 245 | 413 | 142 | 131 | | 101 |
% Margin | 8.8% | 8.8% | 7.5% | 8.5% | 7.2% | 6.5% | 10.5% | 16.0% | 7.8% | 9.8% | | 7.8% |
| | | | | | | | | | | | |
Adjusted EBIT | 432 | 428 | 293 | 418 | 310 | 185 | 21 | 84 | (80) | (84) | | (109) |
% Margin | 7.1% | 6.9% | 4.7% | 5.7% | 4.3% | 3.0% | 0.9% | 3.2% | -4.4% | -6.3% | | -8.4% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 335 | 301 | 222 | 529 | 388 | 202 | 2 | 74 | 4 | 22 | | 51 |
Addback: Unusual Items | 10 | 24 | (16) | 18 | (5) | 35 | 41 | 4 | (20) | (35) | | (55) |
Less: Tax Benefit of Unusual Items (26%) | (3) | (6) | 4 | (5) | 1 | (9) | (11) | (1) | 5 | 9 | | 14 |
Adjusted Net Income | 343 | 318 | 210 | 542 | 384 | 227 | 33 | 77 | (10) | (4) | | 10 |
% Margin | 5.7% | 5.1% | 3.4% | 7.4% | 5.3% | 3.6% | 1.4% | 3.0% | -0.6% | -0.3% | | 0.8% |